Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer’s disease and Parkinson’s disease-Reference-Cited by-同舟云学术

Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer’s disease and Parkinson’s disease

Published:2000-08 Issue:1-2 Volume:113 Page:121-129
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Rusted Jennifer M,Newhouse Paul A,Levin Edward D

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference92 articles.

1. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21;Arendash;Brain Res.,1995

2. Basal forebrain neurons modulate cortical cerebral blood flow: increases by nicotinic cholinergic mechanisms;Arneric;J. Cereb. Blood Flow Metab.,1989

3. Preclinical pharmacology of ABT-418: a prototypical cholinergic channel activator for the potential treatment of Alzheimer’s disease;Arneric;CNS Drugs Rev.,1995

4. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer’s and Parkinson’s diseases;Aubert;J. Neurochem.,1992

5. Evidence that tobacco smoking increases the density of (−)-[3H] nicotine binding sited in human brain;Benwell;J. Neurochem.,1988

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability Enhancement and Skin Permeation Application of Nicotine by Forming Inclusion Complex with β-Cyclodextrin and Methyl-β-Cyclodextrin;Scientia Pharmaceutica;2021-09-28

2. Interactions between reproductive transitions during aging and addiction: promoting translational crosstalk between different fields of research;Behavioural Pharmacology;2020-09-21

3. Molecular Docking Studies and Anti-Alzheimer’s Potential of Isolated Compounds fromTinospora cordifolia;Journal of Biologically Active Products from Nature;2020-03-03

4. Tacrine and its 7-methoxy derivate; time-change concentration in plasma and brain tissue and basic toxicological profile in rats;Drug and Chemical Toxicology;2019-07-01

5. A new outlook on cholinergic interneurons in Parkinson’s disease and L-DOPA-induced dyskinesia;Neuroscience & Biobehavioral Reviews;2018-09